Zobrazeno 1 - 10
of 183 989
pro vyhledávání: '"Recombinant fusion proteins"'
Autor:
Schön K; Pharmacology & Toxicology, Research, CSL Innovation GmbH, Marburg, Hesse, Germany; Institute of Pharmacology, Biochemical-Pharmacological Center, University of Marburg, Marburg, Hesse, Germany., Pestel S; Pharmacology & Toxicology, Research, CSL Innovation GmbH, Marburg, Hesse, Germany., Riedesel J; Pharmacology & Toxicology, Research, CSL Innovation GmbH, Marburg, Hesse, Germany., Seyfert-Brandt W; Recombinant Protein Expression, Research, CSL Innovation GmbH, Marburg, Hesse, Germany., Claar P; Recombinant Protein Expression, Research, CSL Innovation GmbH, Marburg, Hesse, Germany., Herzog E; Pharmacology & Toxicology, Research, CSL Behring LLC, King of Prussia, Pennsylvania, USA., Rezvani-Sharif A; Pharmacology & Toxicology, Research, CSL Limited, Melbourne, Victoria, Australia., Ponnuswamy P; Pharmacology & Toxicology, Research, CSL Innovation GmbH, Marburg, Hesse, Germany. Electronic address: padmapriya.ponnuswamy@cslbehring.com., Nolte MW; Pharmacology & Toxicology, Research, CSL Innovation GmbH, Marburg, Hesse, Germany.
Publikováno v:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Oct; Vol. 22 (10), pp. 2713-2723. Date of Electronic Publication: 2024 Jul 15.
Autor:
Jia K; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing, China., Zhang Y; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing, China., Jiang M; Department of Clinical Laboratory, The 980th Hospital of PLA Joint Logistics Support Force (Bethune International Peace Hospital), Shijiazhuang, China., Cui M; Department of Clinical Laboratory, The 980th Hospital of PLA Joint Logistics Support Force (Bethune International Peace Hospital), Shijiazhuang, China., Wang J; Department of Clinical Laboratory, The 980th Hospital of PLA Joint Logistics Support Force (Bethune International Peace Hospital), Shijiazhuang, China., Zhang J; Department of Clinical Laboratory, The 980th Hospital of PLA Joint Logistics Support Force (Bethune International Peace Hospital), Shijiazhuang, China., Wang H; Department of Clinical Laboratory, The 980th Hospital of PLA Joint Logistics Support Force (Bethune International Peace Hospital), Shijiazhuang, China., Zhao H; Department of Clinical Laboratory, The 980th Hospital of PLA Joint Logistics Support Force (Bethune International Peace Hospital), Shijiazhuang, China., Li M; Department of Clinical Laboratory, The 980th Hospital of PLA Joint Logistics Support Force (Bethune International Peace Hospital), Shijiazhuang, China., Zou Q; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing, China., Zeng H; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing, China.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2406065. Date of Electronic Publication: 2024 Sep 26.
Autor:
Yang J; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China., Song Y; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China., Zhou K; Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China., Li Z; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China., Zhang M; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Jing H; Department of Hematology, Peking University Third Hospital, Beijing, China., Wang Z; Department of Medical Oncology, Linyi Cancer Hospital, Linyi, China., Yu L; Department of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, China., Meng W; ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China., Lu Q; ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China., Tian W; ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China., Shi Y; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China. syuankai@cicams.ac.cn.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2024 Dec 18; Vol. 17 (1), pp. 123. Date of Electronic Publication: 2024 Dec 18.
Autor:
Nakatsumi H; Department of Gastroenterology, National Hospital Organization Hokkaido Medical Center, Sapporo, Japan., Komatsu Y; Division of Cancer Center, Hokkaido University Hospital, Sapporo, Japan., Harada K; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan., Kawamoto Y; Division of Cancer Center, Hokkaido University Hospital, Sapporo, Japan., Yuki S; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan., Sawada K; Department of Medical Oncology, Kushiro Rosai Hospital, Kushiro, Japan., Ishiguro A; Department of Medical Oncology, Teine Keijinkai Hospital, Sapporo, Japan., Sogabe S; Department of Medical Oncology, KKR Sapporo Medical Center, Sapporo, Japan., Ando T; Third Department of Internal Medicine, University of Toyama, Toyama, Japan., Sasaki Y; Department of Medical Oncology, Hakodate Central General Hospital, Hakodate, Japan., Yoshikawa A; Department of Gastroenterology, Japanese Red Cross Kitami Hospital, Kitami, Japan., Nakamura M; Department of Gastroenterology, Sapporo City General Hospital, Sapporo, Japan., Dazai M; Department of Gastroenterology, Sapporo Medical Center NTT EC, Sapporo, Japan., Tateyama M; Department of Internal Medicine, Tomakomai Nissho Hospital, Tomakomai, Japan., Muto O; Department of Medical Oncology, Japanese Red Cross Akita Hospital, Akita, Japan., Kotaka M; Gastrointestinal Cancer Center, Sano Hospital, Kobe, Japan., Sagawa T; Department of Gastroenterology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan., Muranaka T; Department of Internal Medicine, Wakkanai City Hospital, Wakkanai, Japan., Hatanaka K; Department of Gastroenterology, Hakodate Municipal Hospital, Hakodate, Japan., Takagi R; Institute of Health Science Innovation for Medical Care, Hokkaido University Hospital, Sapporo, Japan., Sakata Y; Misawa City Hospital, Misawa, Japan.
Publikováno v:
International journal of cancer [Int J Cancer] 2024 Dec 15; Vol. 155 (12), pp. 2223-2231. Date of Electronic Publication: 2024 Aug 14.
Publikováno v:
Blood [Blood] 2024 Dec 12; Vol. 144 (24), pp. 2560.
Autor:
Desmarest A; Department of Ophthalmology, Duchenne Hospital, Boulogne sur Mer, France., Bouleau J; Department of Ophthalmology, Claude Huriez Hospital, Lille, France., Cassoux N; Department of Oncology-Ophthalmology, Curie Institute, Paris, France.
Publikováno v:
The American journal of case reports [Am J Case Rep] 2024 Dec 09; Vol. 25, pp. e944211. Date of Electronic Publication: 2024 Dec 09.
Autor:
Gattermann N; Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Publikováno v:
Hematology. American Society of Hematology. Education Program [Hematology Am Soc Hematol Educ Program] 2024 Dec 06; Vol. 2024 (1), pp. 443-449.
Autor:
Boyer DS; Retina-Vitreous Associates Medical Group, Beverly Hills, CA, USA., Steinle NC; California Retina Consultants, Santa Barbara, CA, USA., Pearlman JA; Retinal Consultants Medical Group, Sacramento, CA, USA., Stone CM; Asheville Eye Associates, Asheville, NC, USA., Crawford C; Star Retina, Burleson, TX, USA., Gupta S; Retina Specialty Institute, Pensacola, FL, USA., Dugel PU; Retinal Consultants of Arizona, Phoenix, AZ, USA., Baldwin ME; Opthea Limited, Melbourne, Victoria, Australia., Leitch IM; Opthea Limited, Melbourne, Victoria, Australia.
Publikováno v:
Translational vision science & technology [Transl Vis Sci Technol] 2024 Dec 02; Vol. 13 (12), pp. 32.
Autor:
Hoffmann L; Vista Augenklinik Binningen, Hauptstrasse 55, Binningen, 4102, Switzerland., Michels S; Augenklinik Zürich West, Zurich, Switzerland., Eandi C; Hôpital Ophthalmique Jules-Gonin, Lausanne, Switzerland., Karam MA; Augenklinik Zürich West, Zurich, Switzerland., Figueiredo ECO; Hôpital Ophthalmique Jules-Gonin, Lausanne, Switzerland., Hatz K; Vista Augenklinik Binningen, Hauptstrasse 55, Binningen, 4102, Switzerland. Katja.hatz@vista.ch.; Faculty of Medicine, University of Basel, Basel, Switzerland. Katja.hatz@vista.ch.
Publikováno v:
BMC ophthalmology [BMC Ophthalmol] 2024 Dec 02; Vol. 24 (1), pp. 520. Date of Electronic Publication: 2024 Dec 02.
Autor:
García-Alfonso P; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain. Electronic address: pgarcaalfonso@gmail.com., Elez E; Medical Oncology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain., Soto-Alsar J; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain., Páez D; Department of Medical Oncology, Hospital Santa Creu i Sant Pau, U705 CIBERER, Barcelona, Spain., Fernández-Montes A; Department of Medical Oncology, Complexo Hospitalario Universitario de Ourense, Ourense, Spain., Graña B; Department of Medical Oncology, Complexo Hospitalario Universitario A Coruña, Instituto Investigación Biomédica INIBIC, A Coruña, Spain., Salud A; Department of Medical Oncology, Hospital Universitario Arnau de Vilanova de Lleida, Lleida, Spain., Yubero A; Department of Medical Oncology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain., Gómez-España MA; Department of Medical Oncology IMIBIC, Universidad de Córdoba, CIBERONC, Instituto de Salud Carlos III, Hospital Universitario Reina Sofía, Córdoba, Spain., Macías I; Department of Medical Oncology, Hospital Parc Taulí de Sabadell, Barcelona, Spain., Quintero G; Department of Medical Oncology, Hospital Lucus Augusti, Lugo, Spain., López-López C; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, IDIVAL, UNICAN, Santander, Spain., Fernández-Rodríguez T; Department of Medical Oncology, Hospital Son Llatzer, Palma de Mallorca, Spain., Grávalos C; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., González-Flores E; Department of Medical Oncology, Hospital Virgen de las Nieves, Granada, Spain., Guix M; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain., García Paredes B; Department of Medical Oncology, Hospital Clínico San Carlos, Instituto de Investigación Hospital Clínico San Carlos (IdISSC), Universidad Complutense, Madrid, Spain., Reina JJ; Department of Medical Oncology, Complejo Hospitalario Virgen de la Macarena, Sevilla, Spain., Rodríguez Mowbray JR; Department of Medical Oncology, Hospital Virgen del Rocío, Sevilla, Spain., Sastre J; Department of Medical Oncology, Hospital Clínico San Carlos, Instituto de Investigación Hospital Clínico San Carlos (IdISSC), Universidad Complutense, Madrid, Spain., Aranda E; Department of Medical Oncology IMIBIC, Universidad de Córdoba, CIBERONC, Instituto de Salud Carlos III, Hospital Universitario Reina Sofía, Córdoba, Spain.
Publikováno v:
ESMO open [ESMO Open] 2024 Dec; Vol. 9 (12), pp. 103986. Date of Electronic Publication: 2024 Nov 27.